Quantcast
Last updated on April 18, 2014 at 6:20 EDT

Latest osteonecrosis Stories

2013-07-03 23:02:39

d'Oliveira & Associates has released a new infographic detailing the possible risks of Fosamax, including femur fractures and osteonecrosis of the jaw. (PRWEB) July 03, 2013 Fosamax (alendronate) is a drug that is used to treat bone conditions like osteoporosis. This drug is included in the bisphosphonate class of drugs which slow the process of bone loss. It was first approved by the FDA in September 1995. In December 2009 NPR reported that Fosamax has been a blockbuster drug...

2012-12-29 05:00:33

Law firm offers no win - no fee promise for clients injured from the drug Fosamax, used to treat bone-weakening diseases. Fosamax has allegedly been linked to serious side effects, such as femur fractures, osteonecrosis of the jaw injury, esophageal cancer, and severe musculoskeletal pain. (PRWEB) December 28, 2012 Law Firm Offers No Win - No Fee Promise For Clients injured from the drug Fosamax, used to treat bone-weakening diseases. Fosamax has allegedly been linked to serious side...

2012-11-12 11:38:57

Two new studies by researchers at Hospital for Special Surgery have overturned common beliefs about joint replacement in patients with lupus and rheumatoid arthritis (RA). In one study, researchers demonstrated that RA patients who undergo a knee replacement can expect outcomes that are similar to individuals undergoing the operation for osteoarthritis. In the other, investigators showed that lupus patients undergoing joint replacement surgery experienced far fewer adverse events than...

2012-03-09 13:25:00

According to court documents, on February 27th, 2012, a jury trial began in the Superior Court for Atlantic County, New Jersey in In re: Fosamax Litigation (No. 282). Plaintiffs allege that their Fosamax use caused them to develop osteonecrosis of the jaw (ONJ). Fosamax, manufactured by Merck, is a drug approved by the FDA in 1995 to treat post-menopausal osteoporosis and Paget's disease of bone. ONJ is a rare bone disease that can cause the patient's jaw bone to deteriorate and die. The...

2011-02-14 15:54:40

A commonly prescribed osteoporosis drug is associated with a slightly elevated risk of developing the rare, but serious condition, osteonecrosis of the jaw; nonetheless the risk remains extremely low. These findings are published online in the Journal of Dental Research, the official journal of the International and American Associations for Dental Research. Although the findings are provocative, study authors say they should be carefully considered against the large benefit of these drugs to...

2010-12-13 16:52:00

THOUSAND OAKS, Calif., Dec. 13, 3010 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced top-line results from a Phase 3 trial evaluating XGEVA(TM) (denosumab) versus placebo in 1,432 men with castrate-resistant prostate cancer. The trial, known as the '147 study, demonstrated that XGEVA significantly improved median bone metastasis-free survival by 4.2 months (HR=0.85, 95 percent CI 0.73-0.98, p=0.03) compared to placebo (primary endpoint), and significantly improved time to...

80bade0876dca47b498c6ccbe4a1d1d51
2010-10-17 08:55:00

Forteo, a drug produced by Eli Lilly and Co. and used for osteoporosis, has been found to be able to re-grow bone in jaws damaged by severe bone-destroying conditions called osteonecrosis and periodontitis, doctors reported on Saturday.The research suggests that the drug may drive growth in a damaged jaw, according to researchers.Forteo, known as teriparatide generically, cuts the risk of bone fractures by half in patients with thinning bones by stimulating the growth of new bone. But the...

2009-03-09 08:00:00

ADA creates brochures with National Osteoporosis Foundation CHICAGO, March 9 /PRNewswire-USNewswire/ -- Dental patients who have been alarmed or confused by recent news reports about how osteoporosis medications might affect their oral health now have a brochure to help them separate fact from fiction. The American Dental Association (ADA) collaborated with the National Osteoporosis Foundation to create the brochure, "Osteoporosis Medications and Your Dental Health," which will be available...

2009-02-19 10:25:16

You may recall as a child catching the itchy red rash, chicken pox. The unsightly infection was caused by the varicella zoster virus and was responsible for nearly 4 million cases each year, according to the Centers for Disease Control (CDC), until a vaccine introduced in 1995 reduced that number by 83 percent. Yet, if you were among those that suffered from chicken pox, the varicella zoster virus may still be present in your body and could lead to serious (and irreversible) oral health...

2008-09-24 03:00:09

By Zhang, N-F Li, Z R; Wei, H-Y; Liu, Z-H; Hernigou, P Severe acute respiratory syndrome (SARS) is a newly described infectious disease caused by the SARS coronavirus which attacks the immune system and pulmonary epithelium. It is treated with regular high doses of corticosteroids. Our aim was to determine the relationship between the dosage of steroids and the number and distribution of osteonecrotic lesions in patients treated with steroids during the SARS epidemic in Beijing, China in...